BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29573537)

  • 1. Comparison of the planned one- and elective two-stent techniques in patients with coronary bifurcation lesions with or without acute coronary syndrome from the COBIS II Registry.
    Kim MC; Ahn Y; Sun Sim D; Joon Hong Y; Han Kim J; Ho Jeong M; Gwon HC; Kim HS; Rha SW; Yoon JH; Jang Y; Tahk SJ; Seung KB
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1050-1060. PubMed ID: 29573537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Lee JM; Hahn JY; Kang J; Park KW; Chun WJ; Rha SW; Yu CW; Jeong JO; Jeong MH; Yoon JH; Jang Y; Tahk SJ; Gwon HC; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1318-1331. PubMed ID: 26315734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.
    Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Kim HS; Chun WJ; Hur SH; Han SH; Rha SW; Chae IH; Jeong JO; Heo JH; Yoon J; Lim DS; Park JS; Hong MK; Doh JH; Cha KS; Kim DI; Lee SY; Chang K; Hwang BH; Choi SY; Jeong MH; Hong SJ; Nam CW; Koo BK; Gwon HC
    Circ Cardiovasc Interv; 2020 Feb; 13(2):e008543. PubMed ID: 32069106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.
    Song YB; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Lee JH; Yu CW; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Oh JH; Park JS; Gwon HC
    JACC Cardiovasc Interv; 2014 Mar; 7(3):255-63. PubMed ID: 24529936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
    Kalkman DN; Woudstra P; Lu H; Menown IBA; den Heijer P; Suryapranata H; Iñiguez A; Arkenbout KE; Van't Hof AWJ; Muller P; Erglis A; Tijssen JG; Beijk MAM; de Winter RJ
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):E31-E37. PubMed ID: 28145609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting.
    Cho S; Kang TS; Kim JS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Song YB; Hahn JY; Choi SH; Gwon HC; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1247-1258. PubMed ID: 29976361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of bifurcation stent technique on clinical outcomes in patients with a Medina 0,0,1 coronary bifurcation lesion: results from the COBIS (COronary BIfurcation Stenting) II registry.
    Jang WJ; Song YB; Hahn JY; Choi SH; Kim HS; Yu CW; Rha SW; Jang Y; Seung KB; Gwon HC
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):E43-50. PubMed ID: 24659259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
    Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
    Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II.
    Jang WJ; Ahn SG; Song YB; Choi SH; Chun WJ; Oh JH; Cho SW; Kim BS; Yoon JH; Koo BK; Yu CW; Jang YS; Tahk SJ; Kim HS; Gwon HC; Lee SY; Hahn JY
    Circ Cardiovasc Interv; 2018 Jul; 11(7):e005849. PubMed ID: 30006330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Clinical Outcomes of Final Kissing Ballooning in Coronary Bifurcation Lesions Treated With the 1-Stent Technique: Results From the COBIS II Registry (Korean Coronary Bifurcation Stenting Registry).
    Yu CW; Yang JH; Song YB; Hahn JY; Choi SH; Choi JH; Lee HJ; Oh JH; Koo BK; Rha SW; Jeong JO; Jeong MH; Yoon JH; Jang Y; Tahk SJ; Kim HS; Gwon HC
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1297-1307. PubMed ID: 26315732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Long-Term Effects of First- and Second-Generation DES in Patients With Bifurcation Lesions Undergoing PCI.
    Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Kim HS; Chun WJ; Hur SH; Han SH; Rha SW; Chae IH; Jeong JO; Heo JH; Yoon J; Lim DS; Park JS; Hong MK; Doh JH; Cha KS; Kim DI; Lee SY; Chang K; Hwang BH; Choi SY; Jeong MH; Hong SJ; Nam CW; Koo BK; Gwon HC
    JACC Asia; 2021 Jun; 1(1):68-79. PubMed ID: 36338362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of calcified bifurcation lesions in patients undergoing percutaneous coronary intervention using drug-eluting stents: results from the COronary BIfurcation Stent (COBIS) II registry.
    Kim MC; Ahn Y; Sim DS; Hong YJ; Kim JH; Jeong MH; Gwon HC; Kim HS; Rha SW; Yoon JH; Jang Y; Tahk SJ; Seung KB
    EuroIntervention; 2017 Jun; 13(3):338-344. PubMed ID: 27867140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial.
    van der Heijden LC; Kok MM; Lam MK; Danse PW; Schramm AR; Jessurun GA; Tjon Joe Gin RM; van Houwelingen KG; Hautvast RW; Linssen GC; Sen H; Löwik MM; IJzerman MJ; Doggen CJ; von Birgelen C
    Clin Res Cardiol; 2016 Mar; 105(3):206-15. PubMed ID: 26329584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes of the one-stent technique versus the two-stent technique for non-left main true coronary bifurcation disease in the era of drug-eluting stents.
    Koh YS; Kim PJ; Chang K; Park HJ; Jeong MH; Kim HS; Jang Y; Gwon HC; Park SJ; Seung KB
    J Interv Cardiol; 2013 Jun; 26(3):245-53. PubMed ID: 23480867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.